semaglutide/pyridoxine compound Discover if You Qualify for Brello's GLP-1 Plans semaglutide pyridoxine compound Compound Semaglutide

Important safety considerations during the initial treatment period include: Monitoring for severe gastrointestinal symptoms: Persistent vomiting, severe abdominal pain, or signs of pancreatitis (severe upper abdominal pain radiating to the back) require immediate medical evaluation

Diabetes Obes Metab (2022) 24 Suppl 1:1726

Key takeaways for patients: Routine eye exams are essential

Of adults taking or who have previously taken a GLP-1, 62% said they took it for diabetes or heart disease, while four in 10 said they took it to treat obesity

semaglutide was then approved in 2021 under the brand name Wegovy for weight loss